Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Other financing activities (2016 - 2025)

Healthstream (HSTM) has disclosed Other financing activities for 12 consecutive years, with $1.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Other financing activities rose 629.28% to $1.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.5 million, a 126.06% increase, with the full-year FY2025 number at $2.5 million, up 126.06% from a year prior.
  • Other financing activities was $1.3 million for Q4 2025 at Healthstream, up from $121000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $1.3 million in Q4 2025 to a low of -$711000.0 in Q4 2021.
  • A 5-year average of $207684.2 and a median of $20000.0 in 2023 define the central range for Other financing activities.
  • Biggest YoY gain for Other financing activities was 700.0% in 2023; the steepest drop was 89.2% in 2023.
  • Healthstream's Other financing activities stood at -$711000.0 in 2021, then surged by 252.32% to $1.1 million in 2022, then plummeted by 89.2% to $117000.0 in 2023, then skyrocketed by 54.7% to $181000.0 in 2024, then surged by 629.28% to $1.3 million in 2025.
  • Per Business Quant, the three most recent readings for HSTM's Other financing activities are $1.3 million (Q4 2025), $121000.0 (Q3 2025), and $5000.0 (Q2 2025).